Journal guides › Fastest review journals › Infectious Diseases
| # | Journal | Median days | Spread of review times | Impact factor* | Indexed in | Access |
|---|---|---|---|---|---|---|
| 1 | Aids Reviews | 21 | 7–61 | 0.82 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 2 | Current Tropical Medicine Reports | 56 | 47–96 | 2.55 | ESCI, Scopus, JCR 2024 | Hybrid / subscription |
| 3 | Infection and Chemotherapy | 60 | 26–83 | 2.64 | ESCI, Scopus, JCR 2024 | Open access · APC ~US$200 |
| 4 | Transplant Infectious Disease | 62 | 8–104 | 1.74 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 5 | Infection | 64 | 42–99 | 4.03 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 6 | Infectious Diseases and Therapy | 64 | 46–98 | 5.35 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$7,400 |
| 7 | Current Fungal Infection Reports | 72 | 43–99 | 2.11 | ESCI, Scopus, JCR 2024 | Hybrid / subscription |
| 8 | Infectious Diseases in Clinical Practice | 75 | 31–117 | 0.22 | ESCI, Scopus, JCR 2024 | Hybrid / subscription |
| 9 | HIV Research & Clinical Practice | 76 | 59–120 | 1.93 | SCIE, Scopus, JCR 2024 | Open access |
| 10 | European Journal of Clinical Microbiology & Infectious Diseases | 78 | 50–116 | 3.28 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 11 | Infection and Immunity | 78 | 19–115 | 4.00 | SCIE, Scopus, JCR 2024 | Open access |
| 12 | International Journal of Mycobacteriology | 86 | 63–101 | 1.28 | ESCI, Scopus, JCR 2024 | Open access |
| 13 | AIDS Research and Therapy | 91 | 66–143 | 2.34 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$2,990 |
| 14 | Sexually Transmitted Diseases | 91 | 79–128 | 1.45 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 15 | Infectious Diseases & Immunity | 97 | 72–144 | 2.03 | ESCI, Scopus | Open access |
| 16 | The Pediatric Infectious Disease Journal | 101 | 70–133 | 1.92 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 17 | Tropical Diseases Travel Medicine and Vaccines | 102 | 58–141 | 4.22 | ESCI, Scopus, JCR 2024 | Open access · APC ~US$2,790 |
| 18 | AIDS | 103 | 62–134 | 2.09 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 19 | HIV Medicine | 103 | 74–155 | 2.09 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 20 | Expert Review of Anti-infective Therapy | 104 | 69–164 | 4.08 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 21 | Transboundary and Emerging Diseases | 106 | 70–148 | 2.87 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 22 | Journal of Chemotherapy | 114 | 84–160 | 2.47 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 23 | One Health Outlook | 117 | 72–192 | 4.31 | ESCI, JCR 2024 | Open access · APC ~US$1,690 |
| 24 | Emerging Microbes & Infections | 120 | 85–147 | 7.51 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$2,643 |
| 25 | Current HIV Research | 121 | 99–152 | 1.09 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 26 | Infectious Diseases of Poverty | 125 | 102–162 | 6.72 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$2,690 |
| 27 | BMC Infectious Diseases | 126 | 86–197 | 3.18 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$3,090 |
| 28 | Archives of Clinical Infectious Diseases | 134 | 60–240 | 1.53 | ESCI, Scopus, JCR 2024 | Open access |
| 29 | Malaria Journal | 135 | 92–210 | 3.88 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$2,890 |
| 30 | Journal of Global Infectious Diseases | 135 | 82–186 | 1.03 | ESCI, Scopus, JCR 2024 | Open access · APC ~US$400 |
| 31 | Influenza and Other Respiratory Viruses | 140 | 84–192 | 4.02 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$4,840 |
| 32 | Journal of Vector Borne Diseases | 143 | 111–216 | 1.37 | SCIE, Scopus, JCR 2024 | Open access |
| 33 | Journal of Viral Hepatitis | 144 | 99–208 | 1.88 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 34 | Antimicrobial Resistance and Infection Control | 148 | 104–214 | 4.93 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$3,290 |
| 35 | JAIDS Journal of Acquired Immune Deficiency Syndromes | 168 | 119–221 | 2.51 | SCIE, JCR 2024 | Hybrid / subscription |
| 36 | Current HIV/AIDS Reports | 172 | 84–239 | 5.59 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 37 | Virulence | 173 | 132–221 | 5.41 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$2,557 |
| 38 | Canadian Journal of Infectious Diseases and Medical Microbiology | 192 | 141–281 | 2.45 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$2,160 |
| 39 | Zoonoses and Public Health | 195 | 140–244 | 2.74 | SCIE, Scopus, JCR 2024 | Hybrid / subscription |
| 40 | Journal of the International AIDS Society | 202 | 154–252 | 3.60 | SCIE, Scopus, JCR 2024 | Open access · APC ~US$2,600 |
| 41 | AIDS Research and Treatment | 215 | 163–312 | 1.34 | ESCI, Scopus, JCR 2024 | Open access · APC ~US$1,000 |
| 42 | Case Reports in Infectious Diseases | 226 | 148–322 | 0.31 | ESCI, JCR 2024 | Open access · APC ~US$790 |
The box shows the middle half of each journal's papers and the dark line its median. *Impact factor: 2-year citedness from OpenAlex open data, not the official Clarivate value.
Frequently asked questions
Which Infectious Diseases journals have the fastest review?
By median days from submission to acceptance: Aids Reviews (21 days); Current Tropical Medicine Reports (56 days); Infection and Chemotherapy (60 days). Source: dates deposited by the publishers in Crossref, updated 28 October 2026.
Is a fast review journal in Infectious Diseases a good choice?
Review time is one factor. Check the journal’s scope, indexing and impact factor too, and confirm it is not predatory: a very short review with no real reviewer comments is a warning sign. Journal pages on ScholarsColab show all of these together.
Where do these review times come from?
From the received and accepted dates that publishers deposit in Crossref, the scholarly publication registry. ScholarsColab takes the median for each journal over its research articles of the last 24 months. Updated 28 October 2026.
Related: Journal Finder · Journal Directory · How to choose a journal · APC waiver checker
